JNJ Today - Aug 12: Stock Stays Flat Amid Buzz
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
So, what went down? JNJ opened up and then just sorta hung around. No big swings, no crazy drama. It’s like that friend who shows up to the party but just stands by the snack table. The volume was right on point with its average, so people were trading like usual, but nobody was making any wild moves.
Now, why did JNJ stay so chill? Well, there’s a lot of chatter about the company hitting that massive $100 billion revenue mark soon, which is super exciting! But with all that buzz, folks are still debating whether the stock is worth grabbing right now. Some articles even mention it's nearing a 52-week high, which can make investors think twice before diving in. Plus, there’s news about JNJ advancing its Seltorexant treatment for major depressive disorder, which is a big deal. But again, no one really knows what that means for the stock today.
One thing worth noting is that Annex Advisory Services sold over 5,000 shares. That’s a decent chunk, and it could make some investors raise an eyebrow. It’s always interesting when you see big players making moves.
So, yeah, the stock kinda just sat there today. JNJ’s got some exciting stuff on the horizon, but today was just a slow bleed. As always, just remember this is all for fun and info, not advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません